François-Xavier is responsible for delivering the IP and commercialisation strategy of the Babraham Institute. He leads the Intellectual Property (IP), commercialisation, and partnership activities at the Babraham Institute and the Babraham ¶¶Òõ¶ÌÊÓƵ Campus via the Accelerate@Babraham programme.
François-Xavier has a background combining life sciences and business with a MSc in Biotechnology and Enterprise from the University of Exeter and a BSc in Molecular Biology from the Université d’Auvergne/Heriot-Watt University. He is a Registered Technology Transfer Professional and a Certified Licensing Professional.
François-Xavier joined the Institute in 2024. He was previously Senior Business Manager in the technology transfer/partnership team at LifeArc, supporting the translation and commercialisation of innovations arising from the Medical ¶¶Òõ¶ÌÊÓƵ Council, including the MRC Laboratory of Molecular Biology in Cambridge, the UK Dementia ¶¶Òõ¶ÌÊÓƵ Institute and the London School of Hygiene and Tropical Medicine. As part of his role at LifeArc, François-Xavier also provided advice to medical research charities, such as Worldwide Cancer ¶¶Òõ¶ÌÊÓƵer or Debra, on IP and commercialisation matters.
Prior to joining LifeArc in 2015, François-Xavier was an Intellectual Property Analyst at GALVmed, a charity supported by the Bill and Melinda Gates Foundation and the UK Department for International Development, where he was responsible for the management of their grant and IP portfolio.